Animalcare – recommended offer means a near 40% gain in just over six months

In October last year on animal health group Animalcare (ANCR) we noted its then just-announced half-year results included “underlying continuing basic EPS increased by 67.2% to 9.7 pence” and “five major pipeline projects all have considerable market opportunity and unmet need with potential peak sales for each project significantly larger than the group’s current largest product”, which suggested to us significant upside potential from a then 236p offer share price. The shares had since risen to close at 247p… before now a recommended cash offer.

Animalcare (#ANCR) – recommended 336p per share offer from Charterhouse Capital Partners

Animalcare Group – a growth and development potential Buy.

Recently animal health group describing itself as “focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition”, Animalcare (ANCR) announced its results for the first half of the 2025 calendar year including “underlying continuing basic EPS increased by 67.2% to 9.7 pence” and “our five major pipeline projects all have considerable market opportunity and unmet need with potential peak sales for each project significantly larger than the group’s current largest product”. The following is why we consider that combination offers significant upside potential from a 236p offer price for the shares.

Animalcare (#ANCR) – completes acquisition of Randlab

Animalcare (#ANCR) – sale of its majority shareholding in pet microchipping and services business Identicare for £24.9m

Animalcare (#ANCR) – H1 trading “in line”, though delays in “several” new launches, new CEO

Animalcare (#ANCR) – Cortacare product positive recommendation from CVMP, paving way for European launch

As Vets Rake it In, You Would Not Be Barking to View This Firm as a Buying Opportunity

A trip to your local vet these days will show you a waiting room crammed with poorly dogs and cats. The national horde of mutts is growing fast, it seems, to me. And the beaches around here are now absolutely heaving with them. But increasing business for vets doesn’t seem to have lowered their fees much. My local vet is reasonable, but the stories you hear about some other animal medics are horrendous.

Animalcare (#ANCR) – profit warning due to “a changing sales mix and competitive pressures”

Animalcare (#ANCR) – 2017 earnings “expected to be broadly in line with management expectations”

Animalcare (#ANCR) – trading “in line with current market expectations”

Table of shorted AIM shares - week to 07/07/2017

From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2016 and thus far in 2017 (by net short position %) - and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...

Animalcare (#ANCR) – placing, reverse acquisition by Ecuphar NV

Zak Mir's Bull Call Of The Day No.2: Animalcare Group: 200 Day Line Bear Trap Suggests 260p Target

It is interesting that even though Animalcare Group (ANCR) may not be the most high profile company, its recent share price action and accompanying increased volatility have given the shares are rather more dynamic profile of late.